| HGNC Family | Claudins (CLDN) |
| Name | claudin 18 |
| Description | This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. This gene is upregulated in patients with ulcerative colitis and highly overexpressed in infiltrating ductal adenocarcinomas. PKC/MAPK/AP-1 (protein kinase C/mitogen-activated protein kinase/activator protein-1) dependent pathway regulates the expression of this gene in gastric cells. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jun 2010] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Claudin‐18 (CLDN18) is a member of the claudin family of transmembrane proteins that is critical for tight junction assembly, paracellular permeability, and the maintenance of epithelial homeostasis. Importantly, isoform‐specific expression of CLDN18 confers distinct functions in different tissues.\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In the gastric epithelium, the CLDN18.2 isoform is expressed almost exclusively on differentiated epithelial cells of the gastric mucosa. This restricted expression creates a barrier that protects against acid injury, with its loss or down‐regulation resulting in increased paracellular H<sup>+</sup> leak, atrophic gastritis, and metaplastic changes ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "]. In addition, CLDN18.2 is frequently retained or ectopically activated during malignant transformation—not only in primary gastric cancers but also in pancreatic, esophageal, and other epithelial tumors—making it an attractive cell surface target for antibody‐based cancer therapies ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}, {"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "].\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In the lung, the CLDN18.1 isoform is the dominant claudin expressed by alveolar epithelial cells and is essential for maintaining tight junction integrity. Here, CLDN18 regulates junctional composition and paracellular permeability and modulates intracellular signaling pathways such as the Hippo/YAP pathway; its absence results in impaired barrier function, increased progenitor cell proliferation, alveolar fluid clearance abnormalities, and an enhanced propensity for tumorigenesis ["}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "6"}]}, {"type": "t", "text": "]. Similarly, in Barrett’s esophagus the strong up‐regulation of CLDN18 contributes to enhanced acid resistance by reducing paracellular permeability of both sodium and protons ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "].\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In pancreatic and colorectal neoplasms, ectopic activation or overexpression of CLDN18 is observed in precursor lesions as well as in invasive cancers. In pancreatic ductal adenocarcinoma, for example, CLDN18 is up‐regulated through protein kinase C–mediated signaling, and its frequent expression in precancerous lesions makes it a promising diagnostic marker and therapeutic target ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}, {"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "]. In colorectal cancer, CLDN18 expression is associated with a gastric phenotype and correlates with poorer patient survival ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "]. Moreover, the discovery of a fusion between CLDN18 and ARHGAP in young‐onset gastric cancers has been linked to aggressive disease behavior ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "].\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond its role as a barrier component, CLDN18 is also involved in signaling. In kidney and inner ear epithelia—as well as other tissues—CLDN18 contributes to the regulation of ion selectivity and overall barrier integrity, ensuring proper epithelial function ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "]. Disruption of CLDN18 function by cytoskeletal rearrangement or tyrosine phosphorylation can impair tight junction organization, further emphasizing its essential role in maintaining epithelial integrity ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": "].\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, CLDN18 plays multifaceted roles in diverse epithelial tissues: it establishes and maintains tight junctions to control paracellular permeability, safeguards tissue-specific barrier functions against environmental insults (such as gastric acid), modulates intracellular signaling pathways that regulate cell proliferation and differentiation, and—when dysregulated—contributes to pathological states including tumorigenesis. Its tissue‐restricted expression and cancer–associated dysregulation underscore its potential as both a diagnostic marker and a therapeutic target in multiple epithelial cancers ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}, {"type": "fg_f", "ref": "15"}, {"type": "fg_f", "ref": "12"}, {"type": "fg_f", "ref": "7"}, {"type": "fg_f", "ref": "4"}, {"type": "fg_f", "ref": "16"}, {"type": "fg_f", "ref": "2"}, {"type": "fg_f", "ref": "17"}, {"type": "fg_f", "ref": "5"}, {"type": "fg_f", "ref": "3"}, {"type": "fg_f", "ref": "18"}, {"type": "fg_f", "ref": "6"}, {"type": "fg_f", "ref": "8"}, {"type": "fg_f", "ref": "19"}, {"type": "fg_f", "ref": "10"}, {"type": "fg_f", "ref": "9"}, {"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": "].\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ugur Sahin, Michael Koslowski, Karl Dhaene, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-08-1547"}], "href": "https://doi.org/10.1158/1078-0432.CCR-08-1547"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19047087"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19047087"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Daisuke Hayashi, Atsushi Tamura, Hiroo Tanaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deficiency of claudin-18 causes paracellular H+ leakage, up-regulation of interleukin-1β, and atrophic gastritis in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2011.10.040"}], "href": "https://doi.org/10.1053/j.gastro.2011.10.040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22079592"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22079592"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Stefan Wöll, Anna Melissa Schlitter, Karl Dhaene, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.28400"}], "href": "https://doi.org/10.1002/ijc.28400"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23900716"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23900716"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Beiyun Zhou, Per Flodby, Jiao Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI90429"}], "href": "https://doi.org/10.1172/JCI90429"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29400695"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29400695"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Michael J LaFemina, Katherine M Sutherland, Trevor Bentley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Claudin-18 deficiency results in alveolar barrier dysfunction and impaired alveologenesis in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Respir Cell Mol Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1165/rcmb.2013-0456OC"}], "href": "https://doi.org/10.1165/rcmb.2013-0456OC"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24787463"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24787463"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Guanglei Li, Per Flodby, Jiao Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Knockout mice reveal key roles for claudin 18 in alveolar barrier properties and fluid homeostasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Respir Cell Mol Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1165/rcmb.2013-0353OC"}], "href": "https://doi.org/10.1165/rcmb.2013-0353OC"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24588076"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24588076"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Biljana Jovov, Christina M Van Itallie, Nicholas J Shaheen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.00158.2007"}], "href": "https://doi.org/10.1152/ajpgi.00158.2007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17932229"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17932229"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Mariko Tanaka, Junji Shibahara, Noriyoshi Fukushima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Claudin-18 is an early-stage marker of pancreatic carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Histochem Cytochem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1369/0022155411420569"}], "href": "https://doi.org/10.1369/0022155411420569"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21832145"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21832145"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Tatsuya Ito, Takashi Kojima, Hiroshi Yamaguchi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.23095"}], "href": "https://doi.org/10.1002/jcb.23095"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21381080"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21381080"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Miho Matsuda, Kazuhiro Sentani, Tsuyoshi Noguchi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Int (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1440-1827.2010.02587.x"}], "href": "https://doi.org/10.1111/j.1440-1827.2010.02587.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20846265"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20846265"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Izuma Nakayama, Eiji Shinozaki, Seiji Sakata, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.13967"}], "href": "https://doi.org/10.1111/cas.13967"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30771244"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30771244"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jianghui Hou, Aparna Renigunta, Antonio S Gomes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0907724106"}], "href": "https://doi.org/10.1073/pnas.0907724106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19706394"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19706394"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Shin-iciro Kitajiri, Mikio Furuse, Kazumasa Morita, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression patterns of claudins, tight junction adhesion molecules, in the inner ear."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hear Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0378-5955(03)00338-1"}], "href": "https://doi.org/10.1016/s0378-5955(03"}, {"type": "t", "text": "00338-1) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14698084"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14698084"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Anita Sapoznikov, Yoav Gal, Reut Falach, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Early disruption of the alveolar-capillary barrier in a ricin-induced ARDS mouse model: neutrophil-dependent and -independent impairment of junction proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Lung Cell Mol Physiol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajplung.00300.2018"}], "href": "https://doi.org/10.1152/ajplung.00300.2018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30382767"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30382767"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Xiaohui Fang, Arne P Neyrinck, Michael A Matthay, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.119917"}], "href": "https://doi.org/10.1074/jbc.M110.119917"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20554518"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20554518"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Kelly Sweerus, Marrah Lachowicz-Scroggins, Erin Gordon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Claudin-18 deficiency is associated with airway epithelial barrier dysfunction and asthma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Allergy Clin Immunol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jaci.2016.02.035"}], "href": "https://doi.org/10.1016/j.jaci.2016.02.035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27215490"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27215490"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Patrick Micke, Johanna Sofia Margareta Mattsson, Karolina Edlund, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.28857"}], "href": "https://doi.org/10.1002/ijc.28857"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24710653"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24710653"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Yoshiko Matsuda, Shuho Semba, Junya Ueda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gastric and intestinal claudin expression at the invasive front of gastric carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1349-7006.2007.00490.x"}], "href": "https://doi.org/10.1111/j.1349-7006.2007.00490.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17459057"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17459057"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Kyong-Hwa Jun, Ji-Hyun Kim, Ji-Han Jung, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of claudin-7 and loss of claudin-18 correlate with poor prognosis in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Surg (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ijsu.2013.11.022"}], "href": "https://doi.org/10.1016/j.ijsu.2013.11.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24333468"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24333468"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Tadayuki Oshima, Jing Shan, Takuya Okugawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulation of claudin-18 is associated with the proliferative and invasive potential of gastric cancer at the invasive front."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0074757"}], "href": "https://doi.org/10.1371/journal.pone.0074757"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24073219"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24073219"}]}]}]}
|
| Synonyms | SFTPJ, SFTA5 |
| Proteins | CLD18_HUMAN |
| NCBI Gene ID | 51208 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
CLDN18 has 4,424 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 106 datasets.
Click the + buttons to view associations for CLDN18 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by CLDN18 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of CLDN18 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of CLDN18 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of CLDN18 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of CLDN18 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of CLDN18 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of CLDN18 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of CLDN18 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of CLDN18 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of CLDN18 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of CLDN18 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with CLDN18 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of CLDN18 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of CLDN18 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of CLDN18 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of CLDN18 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of CLDN18 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing CLDN18 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing CLDN18 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with CLDN18 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with CLDN18 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of CLDN18 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with CLDN18 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with CLDN18 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with CLDN18 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by CLDN18 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for CLDN18 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with CLDN18 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with CLDN18 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with CLDN18 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with CLDN18 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at CLDN18 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of CLDN18 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of CLDN18 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing CLDN18 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of CLDN18 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with CLDN18 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing CLDN18 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of CLDN18 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of CLDN18 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of CLDN18 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of CLDN18 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of CLDN18 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of CLDN18 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding CLDN18 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving CLDN18 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving CLDN18 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving CLDN18 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing CLDN18 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing CLDN18 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing CLDN18 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by CLDN18 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of CLDN18 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of CLDN18 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of CLDN18 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of CLDN18 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of CLDN18 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with CLDN18 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of CLDN18 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for CLDN18 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of CLDN18 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of CLDN18 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of CLDN18 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of CLDN18 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with CLDN18 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with CLDN18 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by CLDN18 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for CLDN18 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of CLDN18 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of CLDN18 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of CLDN18 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving CLDN18 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving CLDN18 protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate CLDN18 protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of CLDN18 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of CLDN18 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of CLDN18 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of CLDN18 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of CLDN18 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing CLDN18 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain CLDN18 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by CLDN18 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of CLDN18 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by CLDN18 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of CLDN18 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for CLDN18 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of CLDN18 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of CLDN18 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving CLDN18 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving CLDN18 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving CLDN18 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving CLDN18 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of CLDN18 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at CLDN18 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of CLDN18 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of CLDN18 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of CLDN18 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with CLDN18 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of CLDN18 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of CLDN18 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of CLDN18 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of CLDN18 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of CLDN18 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with CLDN18 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with CLDN18 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving CLDN18 protein from the WikiPathways Pathways 2024 dataset. | |